Loading clinical trials...
Loading clinical trials...
Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents
Conditions
Interventions
carboplatin
etoposide
+6 more
Locations
54
Germany
Universitätskinderklinik Aachen
Aachen, Germany
Klinikum Augsburg, Klinik für Kinder- und Jugendmedizin
Augsburg, Germany
Helios Klinikum Berlin-Buch, Klinik für Kinderheilkunde und Jugendmedizin
Berlin, Germany
Charité Klinikum Campus Virchow, Kinderklinik
Berlin, Germany
Klinik ür Kinder- und Jugendmedizin in Bethel
Bielefeld, Germany
Universitätskinderklinik Bonn
Bonn, Germany
Start Date
February 1, 2006
Primary Completion Date
January 31, 2015
Completion Date
January 31, 2016
Last Updated
July 20, 2018
Lead Sponsor
University Hospital, Bonn
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions